Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Idelalisib | hsa00020 | Citrate cycle (TCA cycle) | 3.41E-02 | 2 | P50213, O14521 | IDH3A, SDHD | More | | Idelalisib | hsa00030 | Pentose phosphate pathway | 1.69E-02 | 2 | P60891, P37837 | PRPS1, TALDO1 | More | | Idelalisib | hsa00040 | Pentose and glucuronate interconversions | 3.53E-02 | 1 | O60701 | UGDH | More | | Idelalisib | hsa00051 | Fructose and mannose metabolism | 2.84E-04 | 5 | P15121, P19367, P08237, P60174, P04075 | AKR1B1, HK1, PFKM, TPI1, ALDOA | More | | Idelalisib | hsa00052 | Galactose metabolism | 3.77E-04 | 5 | P06280, P08237, O43451, P15121, P19367 | GLA, PFKM, MGAM, AKR1B1, HK1 | More | | Idelalisib | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Idelalisib | hsa00190 | Oxidative phosphorylation | 1.94E-06 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Idelalisib | hsa00220 | Arginine biosynthesis | 1.26E-03 | 3 | P15104, P05089, P49448 | GLUL, ARG1, GLUD2 | More | | Idelalisib | hsa00230 | Purine metabolism | 4.93E-02 | 1 | P21589 | NT5E | More | | Idelalisib | hsa00240 | Pyrimidine metabolism | 1.81E-02 | 1 | P21589 | NT5E | More | | Idelalisib | hsa00250 | Alanine, aspartate and glutamate metabolism | 2.42E-02 | 1 | P15104 | GLUL | More | | Idelalisib | hsa00310 | Lysine degradation | 2.36E-03 | 4 | Q96KQ7, Q8NEZ4, Q13029, P51648 | EHMT2, MLL3, PRDM2, ALDH3A2 | More | | Idelalisib | hsa00500 | Starch and sucrose metabolism | 3.06E-05 | 4 | O43451, P46976, P35573, P06737 | MGAM, GYG1, AGL, PYGL | More | | Idelalisib | hsa00510 | N-Glycan biosynthesis | 3.15E-02 | 2 | P15907, Q9NR34 | ST6GAL1, MAN1C1 | More | | Idelalisib | hsa00513 | Various types of N-glycan biosynthesis | 4.83E-02 | 1 | Q9NR34 | MAN1C1 | More | | Idelalisib | hsa00520 | Amino sugar and nucleotide sugar metabolism | 7.84E-04 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | | Idelalisib | hsa00562 | Inositol phosphate metabolism | 1.45E-03 | 3 | Q14642, P29218, P19174 | INPP5A, IMPA1, PLCG1 | More | | Idelalisib | hsa00563 | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 3.01E-02 | 1 | Q14442 | PIGH | More | | Idelalisib | hsa00564 | Glycerophospholipid metabolism | 3.49E-04 | 7 | P48651, Q9Y6K0, P35790, Q9Y259, P23743, P49619, Q3LIE5 | PTDSS1, CEPT1, CHKA, CHKB, DGKA, DGKG, ADPRM | More | | Idelalisib | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | | Idelalisib | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Idelalisib | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | | Idelalisib | hsa00600 | Sphingolipid metabolism | 1.77E-03 | 4 | Q9BX95, Q8TCT0, Q06136, P15289 | SGPP1, CERK, FVT1, ARSA | More | | Idelalisib | hsa00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 7.02E-03 | 2 | P06865, O75752 | HEXA, B3GALNT1 | More | | Idelalisib | hsa00630 | Glyoxylate and dicarboxylate metabolism | 1.57E-05 | 3 | P40925, P40926, P15104 | MDH1, MDH2, GLUL | More | | Idelalisib | hsa00640 | Propanoate metabolism | 3.83E-02 | 2 | Q02252, Q9P2R7 | ALDH6A1, SUCLA2 | More | | Idelalisib | hsa00670 | One carbon pool by folate | 7.39E-04 | 3 | O95954, P04818, Q99707 | FTCD, TYMS, MTR | More | | Idelalisib | hsa00730 | Thiamine metabolism | 1.55E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Idelalisib | hsa00740 | Riboflavin metabolism | 4.77E-02 | 1 | P30043 | BLVRB | More | | Idelalisib | hsa00760 | Nicotinate and nicotinamide metabolism | 9.09E-03 | 1 | P21589 | NT5E | More | | Idelalisib | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | | Idelalisib | hsa00785 | Lipoic acid metabolism | 4.32E-02 | 1 | Q9Y234 | LIPT1 | More | | Idelalisib | hsa00830 | Retinol metabolism | 2.17E-03 | 4 | P00325, P00352, Q9BPW9, O75911 | ADH1B, ALDH1A1, DHRS9, DHRS3 | More | | Idelalisib | hsa00860 | Porphyrin and chlorophyll metabolism | 8.96E-04 | 2 | P36551, P30043 | CPOX, BLVRB | More | | Idelalisib | hsa00910 | Nitrogen metabolism | 2.42E-02 | 1 | P15104 | GLUL | More | | Idelalisib | hsa00970 | Aminoacyl-tRNA biosynthesis | 2.12E-02 | 1 | P14868 | DARS | More | | Idelalisib | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Idelalisib | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Idelalisib | hsa00983 | Drug metabolism - other enzymes | 1.43E-03 | 3 | P04183, P32320, P05164 | TK1, CDA, MPO | More | | Idelalisib | hsa01040 | Biosynthesis of unsaturated fatty acids | 2.92E-02 | 2 | P22307, Q9H5J4 | SCP2, ELOVL6 | More | | Idelalisib | hsa01100 | Metabolic pathways | 5.45E-04 | 45 | Q9NR34, Q9Y234, P35790, P05089, Q16772, P30041, P19367, P48426, Q14642, P29218, P22557, P32320, P20839, P22748, P55809, P06280, Q16875, O43286, O43451, Q9Y6K0, Q14376, P05186, P24666, P15121, P08237, O95861, P07101, Q9HCC0, P33121, Q9UHK6, Q86VZ5, P48651, P57054, Q9UNP4, Q9BX95, P32321, Q9BPW9, O75911, Q9UHY7, P43490, P46976, P06737, Q969G6, P14927, P12074 | MAN1C1, LIPT1, CHKA, ARG1, GSTA3, PRDX6, HK1, PIP4K2A, INPP5A, IMPA1, ALAS2, CDA, IMPDH1, CA4, OXCT1, GLA, PFKFB3, B4GALT5, MGAM, CEPT1, GALE, ALPL, ACP1, AKR1B1, PFKM, BPNT1, TH, MCCC2, ACSL1, AMACR, SGMS1, PTDSS1, PIGP, ST3GAL5, SGPP1, DCTD, DHRS9, DHRS3, ENOPH1, PBEF1, GYG1, PYGL, RFK, UQCRB, COX6A1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9NR34 | MAN1C1 | Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC | -0.716 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | Q9Y234 | LIPT1 | Lipoyltransferase 1, mitochondrial | 0.829 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P35790 | CHKA | Choline kinase alpha | -0.778 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05089 | ARG1 | Arginase-1 | 0.702 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | Q16772 | GSTA3 | Glutathione S-transferase A3 | -0.791 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P30041 | PRDX6 | Peroxiredoxin-6 | 0.893 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P19367 | HK1 | Hexokinase-1 | 0.777 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P48426 | PIP4K2A | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha | 0.745 | Q09472 | EP300 | Histone acetyltransferase p300 | Q14642 | INPP5A | Inositol polyphosphate-5-phosphatase A | 0.7 | Q09472 | EP300 | Histone acetyltransferase p300 | P29218 | IMPA1 | Inositol monophosphatase 1 | 0.772 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P22557 | ALAS2 | 5-aminolevulinate synthase, erythroid-specific, mitochondrial | 0.707 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32320 | CDA | Cytidine deaminase | 0.701 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | 0.828 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P22748 | CA4 | Carbonic anhydrase 4 | 0.767 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P55809 | OXCT1 | Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial | -0.746 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06280 | GLA | Alpha-galactosidase A | 0.714 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | 0.849 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43286 | B4GALT5 | Beta-1,4-galactosyltransferase 5 | 0.917 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43451 | MGAM | Maltase-glucoamylase | 0.871 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | Q9Y6K0 | CEPT1 | Choline/ethanolaminephosphotransferase 1 | 0.802 | Q09472 | EP300 | Histone acetyltransferase p300 | Q14376 | GALE | UDP-glucose 4-epimerase | -0.905 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | 0.901 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P24666 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | -0.832 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | 0.732 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P08237 | PFKM | ATP-dependent 6-phosphofructokinase, muscle type | 0.82 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | O95861 | BPNT1 | 3'(2'),5'-bisphosphate nucleotidase 1 | -0.702 | Q09472 | EP300 | Histone acetyltransferase p300 | P07101 | TH | Tyrosine 3-monooxygenase | -0.739 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9HCC0 | MCCC2 | Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial | -0.782 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | 0.886 | Q09472 | EP300 | Histone acetyltransferase p300 | Q9UHK6 | AMACR | Alpha-methylacyl-CoA racemase | 0.848 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | Q86VZ5 | SGMS1 | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | -0.795 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P48651 | PTDSS1 | Phosphatidylserine synthase 1 | 0.802 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P57054 | PIGP | Phosphatidylinositol N-acetylglucosaminyltransferase subunit P | -0.881 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UNP4 | ST3GAL5 | Lactosylceramide alpha-2,3-sialyltransferase | -0.819 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.743 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32321 | DCTD | Deoxycytidylate deaminase | -0.748 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | 0.817 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O75911 | DHRS3 | Short-chain dehydrogenase/reductase 3 | -0.81 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UHY7 | ENOPH1 | Enolase-phosphatase E1 | -0.737 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.883 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P46976 | GYG1 | Glycogenin-1 | 0.817 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06737 | PYGL | Glycogen phosphorylase, liver form | 0.863 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | Q969G6 | RFK | Riboflavin kinase | 0.797 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P14927 | UQCRB | Cytochrome b-c1 complex subunit 7 | 0.721 | Q09472 | EP300 | Histone acetyltransferase p300 | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | -0.778 |
| Idelalisib | hsa01230 | Biosynthesis of amino acids | 1.29E-05 | 9 | P60174, P04075, P51854, P60891, Q99707, O75390, P50213, P15104, P37837 | TPI1, ALDOA, TKTL1, PRPS1, MTR, CS, IDH3A, GLUL, TALDO1 | More | | Idelalisib | hsa01240 | Biosynthesis of cofactors | 3.44E-03 | 5 | Q969G6, P36551, P22557, O60701, Q9Y234 | RFK, CPOX, ALAS2, UGDH, LIPT1 | More | | Idelalisib | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 3.18E-04 | 2 | P04049, P08069 | RAF1, IGF1R | More | | Idelalisib | hsa01522 | Endocrine resistance | 2.60E-04 | 8 | P22694, P04049, Q02750, Q9UM47, P46527, P08069, P10415, Q13323 | PRKACB, RAF1, MAP2K1, NOTCH3, CDKN1B, IGF1R, BCL2, BIK | More | | Idelalisib | hsa01523 | Antifolate resistance | 1.68E-02 | 2 | Q92820, P04818 | GGH, TYMS | More | | Idelalisib | hsa01524 | Platinum drug resistance | 4.78E-02 | 1 | P31751 | AKT2 | More | | Idelalisib | hsa02010 | ABC transporters | 1.39E-04 | 2 | P45844, Q8IZY2 | ABCG1, ABCA7 | More | | Idelalisib | hsa03008 | Ribosome biogenesis in eukaryotes | 1.88E-02 | 3 | O14980, O60832, Q9BVP2 | XPO1, DKC1, GNL3 | More | | Idelalisib | hsa03013 | RNA transport | 2.45E-11 | 19 | O14980, P52298, Q09161, O14893, P61326, P38919, Q9H307, P37198, Q7Z3B4, P35658, Q14152, P55884, O75822, Q14240, Q9BZI7, P23588, Q9Y6A5, Q06787, P51114 | XPO1, NCBP2, NCBP1, GEMIN2, MAGOH, EIF4A3, PNN, NUP62, NUP54, NUP214, EIF3A, EIF3B, EIF3J, EIF4A2, UPF3B, EIF4B, TACC3, FMR1, FXR1 | More | | Idelalisib | hsa03015 | mRNA surveillance pathway | 4.81E-02 | 2 | Q9BZI7, O94913 | UPF3B, PCF11 | More | | Idelalisib | hsa03020 | RNA polymerase | 1.64E-03 | 3 | P30876, P24928, P62487 | POLR2B, POLR2A, POLR2G | More | | Idelalisib | hsa03040 | Spliceosome | 4.66E-10 | 19 | Q14562, O43143, O60508, P17844, P08579, P26368, O75940, P51991, P61978, O75494, Q13595, Q07955, Q01130, P84103, Q13243, P11142, Q9Y2W2, O43447, O75643 | DHX8, DHX15, CDC40, DDX5, SNRPB2, U2AF2, SMNDC1, HNRPA3, HNRPK, FUSIP1, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, PPIH, ASCC3L1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | 0.776 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | -0.708 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | -0.853 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.787 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | -0.818 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.837 | P07948 | LYN | Tyrosine-protein kinase Lyn | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.814 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P17844 | DDX5 | Probable ATP-dependent RNA helicase DDX5 | 0.73 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.702 | P07948 | LYN | Tyrosine-protein kinase Lyn | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.739 | P07948 | LYN | Tyrosine-protein kinase Lyn | P26368 | U2AF2 | Splicing factor U2AF 65 kDa subunit | -0.775 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | O75940 | SMNDC1 | Survival of motor neuron-related-splicing factor 30 | -0.816 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | O75940 | SMNDC1 | Survival of motor neuron-related-splicing factor 30 | 0.786 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P51991 | HNRPA3 | Heterogeneous nuclear ribonucleoprotein A3 | 0.787 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P61978 | HNRPK | Heterogeneous nuclear ribonucleoprotein K | 0.827 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | O75494 | FUSIP1 | Serine/arginine-rich splicing factor 10 | -0.718 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | O75494 | FUSIP1 | Serine/arginine-rich splicing factor 10 | 0.73 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q13595 | TRA2A | Transformer-2 protein homolog alpha | -0.742 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.864 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | -0.776 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.743 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.835 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.758 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.716 | P07948 | LYN | Tyrosine-protein kinase Lyn | P84103 | SFRS3 | Serine/arginine-rich splicing factor 3 | -0.79 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.805 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.87 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.781 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.754 | P07948 | LYN | Tyrosine-protein kinase Lyn | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | -0.732 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.709 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q9Y2W2 | WBP11 | WW domain-binding protein 11 | -0.734 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | -0.761 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | 0.762 | P07948 | LYN | Tyrosine-protein kinase Lyn | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | -0.742 |
| Idelalisib | hsa03050 | Proteasome | 4.83E-02 | 1 | P55036 | PSMD4 | More | | Idelalisib | hsa03060 | Protein export | 4.42E-02 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | | Idelalisib | hsa03450 | Non-homologous end-joining | 1.58E-04 | 3 | Q9NP87, P78527, P13010 | POLM, PRKDC, XRCC5 | More | | Idelalisib | hsa03460 | Fanconi anemia pathway | 2.71E-02 | 1 | O94782 | USP1 | More | | Idelalisib | hsa04010 | MAPK signaling pathway | 1.69E-03 | 2 | P04049, P08069 | RAF1, IGF1R | More | | Idelalisib | hsa04012 | ErbB signaling pathway | 6.84E-04 | 5 | P16333, Q13191, P19174, P01106, P04049 | NCK1, CBLB, PLCG1, MYC, RAF1 | More | | Idelalisib | hsa04014 | Ras signaling pathway | 1.00E-05 | 15 | Q02750, P04049, P31751, P20827, Q15389, Q9NRA1, P49767, P08069, P17252, P21359, P0DP23, P62873, P62879, P19174, P22694 | MAP2K1, RAF1, AKT2, EFNA1, ANGPT1, PDGFC, VEGFC, IGF1R, PRKCA, NF1, CALM1, GNB1, GNB2, PLCG1, PRKACB | More | | Idelalisib | hsa04015 | Rap1 signaling pathway | 5.94E-05 | 10 | P04049, P20827, Q9NRA1, P49767, P08069, P11215, P31751, P0DP23, P17252, P19174 | RAF1, EFNA1, PDGFC, VEGFC, IGF1R, ITGAM, AKT2, CALM1, PRKCA, PLCG1 | More | | Idelalisib | hsa04020 | Calcium signaling pathway | 2.71E-03 | 7 | P27987, P17252, P19174, P0DP23, P20020, Q9NRA1, P49767 | ITPKB, PRKCA, PLCG1, CALM1, ATP2B1, PDGFC, VEGFC | More | | Idelalisib | hsa04022 | cGMP-PKG signaling pathway | 2.62E-04 | 3 | P04049, P31751, P0DP23 | RAF1, AKT2, CALM1 | More | | Idelalisib | hsa04024 | cAMP signaling pathway | 1.30E-04 | 3 | P31751, P0DP23, P04049 | AKT2, CALM1, RAF1 | More | | Idelalisib | hsa04060 | Cytokine-cytokine receptor interaction | 8.46E-04 | 14 | P14784, P27930, P14778, P37173, P26842, Q06643, Q13651, P78552, P25024, Q9UBD3, P47992, P09341, P80075, P01730 | IL2RB, IL1R2, IL1R1, TGFBR2, CD27, LTB, IL10RA, IL13RA1, CXCR1, XCL2, XCL1, CXCL1, CCL8, CD4 | More | | Idelalisib | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 1.70E-03 | 8 | P09341, P19875, P25024, P25025, P47992, Q9UBD3, Q13651, P14784 | CXCL1, CXCL2, CXCR1, CXCR2, XCL1, XCL2, IL10RA, IL2RB | More | | Idelalisib | hsa04062 | Chemokine signaling pathway | 1.90E-04 | 14 | P25024, P25025, P09341, P19875, P47992, Q9UBD3, P07948, P42338, P19174, P63218, P50151, P43250, Q08881, P04049 | CXCR1, CXCR2, CXCL1, CXCL2, XCL1, XCL2, LYN, PIK3CB, PLCG1, GNG5, GNG10, GRK6, ITK, RAF1 | More | | Idelalisib | hsa04064 | NF-kappa B signaling pathway | 4.81E-12 | 26 | P10415, Q13489, P51617, O00463, Q13546, P14778, P01584, P01375, P29965, P19174, Q04759, Q9UDY8, Q13077, Q16548, P07948, P06239, Q8WV28, Q13315, P63279, P24522, Q8NHW4, P09341, P19875, Q06643, Q9UNE0, Q9NQC7 | BCL2, BIRC3, IRAK1, TRAF5, RIPK1, IL1R1, IL1B, TNF, CD40LG, PLCG1, PRKCQ, MALT1, TRAF1, BCL2A1, LYN, LCK, BLNK, ATM, UBE2I, GADD45A, CCL4L2, CXCL1, CXCL2, LTB, EDAR, CYLD | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P17252 | PRKCA | Protein kinase C alpha type | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.844 | P05164 | MPO | Myeloperoxidase | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.81 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.744 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.807 | P17252 | PRKCA | Protein kinase C alpha type | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.849 | P08235 | NR3C2 | Mineralocorticoid receptor | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.868 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | 1 | P05164 | MPO | Myeloperoxidase | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.821 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.837 | P06239 | LCK | Tyrosine-protein kinase Lck | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.718 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.945 | P08235 | NR3C2 | Mineralocorticoid receptor | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | -0.749 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.76 | P06239 | LCK | Tyrosine-protein kinase Lck | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.782 | Q13547 | HDAC1 | Histone deacetylase 1 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.854 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P01584 | IL1B | Interleukin-1 beta | 0.799 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 | P17252 | PRKCA | Protein kinase C alpha type | P29965 | CD40LG | CD40 ligand | 0.788 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P05164 | MPO | Myeloperoxidase | Q04759 | PRKCQ | Protein kinase C theta type | -0.88 | P06239 | LCK | Tyrosine-protein kinase Lck | Q04759 | PRKCQ | Protein kinase C theta type | 0.779 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q04759 | PRKCQ | Protein kinase C theta type | 0.803 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P17252 | PRKCA | Protein kinase C alpha type | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.769 | P08235 | NR3C2 | Mineralocorticoid receptor | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.708 | P05164 | MPO | Myeloperoxidase | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | -0.758 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.721 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.741 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.73 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13077 | TRAF1 | TNF receptor-associated factor 1 | 0.83 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | 0.801 | P05164 | MPO | Myeloperoxidase | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.782 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.875 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.877 | P06239 | LCK | Tyrosine-protein kinase Lck | P07948 | LYN | Tyrosine-protein kinase Lyn | -0.701 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.774 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P17252 | PRKCA | Protein kinase C alpha type | Q8WV28 | BLNK | B-cell linker protein | 0.838 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q8WV28 | BLNK | B-cell linker protein | -0.816 | P17252 | PRKCA | Protein kinase C alpha type | Q13315 | ATM | Serine-protein kinase ATM | 0.739 | P05164 | MPO | Myeloperoxidase | Q13315 | ATM | Serine-protein kinase ATM | -0.725 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13315 | ATM | Serine-protein kinase ATM | 0.752 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.756 | P05164 | MPO | Myeloperoxidase | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.812 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.796 | P06239 | LCK | Tyrosine-protein kinase Lck | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.724 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.75 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.802 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.802 | P05164 | MPO | Myeloperoxidase | P09341 | CXCL1 | Growth-regulated alpha protein | 0.806 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.7 | P06239 | LCK | Tyrosine-protein kinase Lck | P09341 | CXCL1 | Growth-regulated alpha protein | -0.805 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P09341 | CXCL1 | Growth-regulated alpha protein | -0.802 | Q13547 | HDAC1 | Histone deacetylase 1 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.736 | Q13547 | HDAC1 | Histone deacetylase 1 | P19875 | CXCL2 | C-X-C motif chemokine 2 | -0.862 | P06239 | LCK | Tyrosine-protein kinase Lck | Q06643 | LTB | Lymphotoxin-beta | 0.846 | Q13547 | HDAC1 | Histone deacetylase 1 | Q06643 | LTB | Lymphotoxin-beta | 0.74 | P08235 | NR3C2 | Mineralocorticoid receptor | Q9UNE0 | EDAR | Tumor necrosis factor receptor superfamily member EDAR | 0.819 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q9NQC7 | CYLD | Ubiquitin carboxyl-terminal hydrolase CYLD | 0.825 |
| Idelalisib | hsa04066 | HIF-1 signaling pathway | 1.49E-02 | 5 | P08069, P17252, Q15389, Q02750, P46527 | IGF1R, PRKCA, ANGPT1, MAP2K1, CDKN1B | More | | Idelalisib | hsa04068 | FoxO signaling pathway | 3.80E-04 | 2 | P04049, P08069 | RAF1, IGF1R | More | | Idelalisib | hsa04070 | Phosphatidylinositol signaling system | 1.86E-07 | 11 | P19174, P0DP23, Q14643, P23743, P49619, Q86XP1, P29218, Q14642, P27987, Q96DU7, P17252 | PLCG1, CALM1, ITPR1, DGKA, DGKG, DGKH, IMPA1, INPP5A, ITPKB, ITPKC, PRKCA | More | | Idelalisib | hsa04071 | Sphingolipid signaling pathway | 1.82E-03 | 7 | P04049, P17252, P21453, Q9H228, Q13362, Q9BX95, P10415 | RAF1, PRKCA, S1PR1, EDG8, PPP2R5C, SGPP1, BCL2 | More | | Idelalisib | hsa04072 | Phospholipase D signaling pathway | 2.31E-02 | 6 | P04049, P42338, P43657, P25024, P25025, P19174 | RAF1, PIK3CB, P2RY5, CXCR1, CXCR2, PLCG1 | More | | Idelalisib | hsa04080 | Neuroactive ligand-receptor interaction | 3.22E-02 | 7 | P08311, Q15722, P21453, Q9H228, O00398, P21730, Q16581 | CTSG, LTB4R, S1PR1, EDG8, P2RY10, C5AR1, C3AR1 | More | | Idelalisib | hsa04110 | Cell cycle | 3.67E-06 | 9 | Q9UBD5, P06493, O60566, P78527, Q14683, P30304, P33981, P42773, P01106 | ORC3, CDK1, BUB1B, PRKDC, SMC1A, CDC25A, TTK, CDKN2C, MYC | More | | Idelalisib | hsa04114 | Oocyte meiosis | 1.41E-04 | 6 | Q9Y6D9, P51812, Q02750, P16298, Q17RY0, P08069 | MAD1L1, RPS6KA3, MAP2K1, PPP3CB, CPEB4, IGF1R | More | | Idelalisib | hsa04115 | p53 signaling pathway | 3.98E-02 | 5 | P24522, Q13315, Q53FA7, O95067, P10415 | GADD45A, ATM, TP53I3, CCNB2, BCL2 | More | | Idelalisib | hsa04120 | Ubiquitin mediated proteolysis | 1.08E-03 | 6 | Q9UBT2, Q14145, Q13042, P62837, Q15751, Q14669 | SAE2, KEAP1, CDC16, UBE2D2, HERC1, TRIP12 | More | | Idelalisib | hsa04136 | Autophagy - other | 5.92E-03 | 2 | O94817, Q9H1Y0 | ATG12, ATG5 | More | | Idelalisib | hsa04137 | Mitophagy - animal | 1.41E-03 | 3 | P67870, P19532, P18848 | CSNK2B, TFE3, ATF4 | More | | Idelalisib | hsa04140 | Autophagy - animal | 4.11E-02 | 7 | P08069, P04049, P22694, Q14643, P10415, Q9H1Y0, Q04759 | IGF1R, RAF1, PRKACB, ITPR1, BCL2, ATG5, PRKCQ | More | | Idelalisib | hsa04141 | Protein processing in endoplasmic reticulum | 1.91E-03 | 6 | P18848, Q15437, Q99941, P11142, P07900, Q9NR31 | ATF4, SEC23B, CREBL1, HSPA8, HSP90AA1, SAR1A | More | | Idelalisib | hsa04142 | Lysosome | 2.45E-03 | 9 | Q99437, P25774, P06865, P22304, P38571, Q13510, P07602, Q9NRA2, P61916 | ATP6V0B, CTSS, HEXA, IDS, LIPA, ASAH1, PSAP, SLC17A5, NPC2 | More | | Idelalisib | hsa04144 | Endocytosis | 1.13E-03 | 14 | Q13191, P0DMV8, P11142, Q9H444, O75351, P62491, P25024, Q96B97, P43250, Q15438, Q14161, P14784, Q9UMY4, Q9Y5X3 | CBLB, HSPA1A, HSPA8, CHMP4B, VPS4B, RAB11A, CXCR1, SH3KBP1, GRK6, PSCD1, GIT2, IL2RB, SNX12, SNX5 | More | | Idelalisib | hsa04145 | Phagosome | 4.65E-05 | 13 | O75015, Q15080, P14598, Q13509, P68371, Q13488, Q99437, P05164, P78380, O60603, P35443, P13765, P25774 | FCGR3B, NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, ATP6V0B, MPO, OLR1, TLR2, THBS4, HLA-DOB, CTSS | More | | Idelalisib | hsa04150 | mTOR signaling pathway | 1.32E-03 | 5 | P08069, P04049, Q02750, Q9NQL2, P51812 | IGF1R, RAF1, MAP2K1, RRAGD, RPS6KA3 | More | | Idelalisib | hsa04151 | PI3K-Akt signaling pathway | 1.13E-03 | 16 | P62753, P25116, P27348, P49767, Q13362, P07900, P62873, P16144, P22105, O60603, P01568, Q99941, P18848, P10415, P17252, O00141 | RPS6, F2R, YWHAQ, VEGFC, PPP2R5C, HSP90AA1, GNB1, ITGB4, TNXB, TLR2, IFNA21, CREBL1, ATF4, BCL2, PRKCA, SGK | More | | Idelalisib | hsa04152 | AMPK signaling pathway | 1.99E-02 | 1 | P08069 | IGF1R | More | | Idelalisib | hsa04210 | Apoptosis | 4.14E-03 | 9 | Q13315, P10415, O76075, P24522, Q16548, P43234, P18848, Q14643, P04049 | ATM, BCL2, DFFB, GADD45A, BCL2A1, CTSO, ATF4, ITPR1, RAF1 | More | | Idelalisib | hsa04211 | Longevity regulating pathway | 1.71E-04 | 7 | Q12778, P08069, P51828, Q99941, P18848, Q9UEF7, Q96KQ7 | FOXO1, IGF1R, ADCY7, CREBL1, ATF4, KL, EHMT2 | More | | Idelalisib | hsa04213 | Longevity regulating pathway - multiple species | 3.95E-05 | 8 | P42338, P08069, Q9Y4H2, Q08828, P51828, P0DMV8, P11142, Q13547 | PIK3CB, IGF1R, IRS2, ADCY1, ADCY7, HSPA1A, HSPA8, HDAC1 | More | | Idelalisib | hsa04217 | Necroptosis | 2.89E-07 | 14 | P01375, P01568, P48023, Q13489, Q13546, P42224, Q14765, P08238, Q6FI13, Q99878, Q93077, P10415, O43633, Q08752 | TNF, IFNA21, FASLG, BIRC3, RIPK1, STAT1, STAT4, HSP90AB1, H2AC18; H2AC19, H2AC14, HIST1H2AC, BCL2, CHMP2A, PPID | More | | Idelalisib | hsa04218 | Cellular senescence | 1.14E-04 | 7 | P31751, P04049, P0DP23, P01889, P10321, P05141, P12236 | AKT2, RAF1, CALM1, HLA-B, HLA-C, SLC25A5, SLC25A6 | More | | Idelalisib | hsa04261 | Adrenergic signaling in cardiomyocytes | 2.02E-04 | 10 | P09493, P51828, P31751, Q99941, P18848, Q13362, P0DP23, Q13557, P17252, P10415 | TPM1, ADCY7, AKT2, CREBL1, ATF4, PPP2R5C, CALM1, CAMK2D, PRKCA, BCL2 | More | | Idelalisib | hsa04270 | Vascular smooth muscle contraction | 2.48E-04 | 7 | P0DP23, P04049, Q08828, P51828, P35579, P35749, P35318 | CALM1, RAF1, ADCY1, ADCY7, MYH9, MYH11, ADM | More | | Idelalisib | hsa04310 | Wnt signaling pathway | 1.48E-03 | 3 | O15169, P17612, P67870 | AXIN1, PRKACA, CSNK2B | More | | Idelalisib | hsa04330 | Notch signaling pathway | 2.77E-02 | 2 | Q92542, P49768 | NCSTN, PSEN1 | More | | Idelalisib | hsa04340 | Hedgehog signaling pathway | 1.04E-04 | 4 | P17612, Q9Y496, O43791, P30279 | PRKACA, KIF3A, SPOP, CCND2 | More | | Idelalisib | hsa04360 | Axon guidance | 5.35E-04 | 6 | P16333, P20827, O95631, P17252, P04049, P19174 | NCK1, EFNA1, NTN1, PRKCA, RAF1, PLCG1 | More | | Idelalisib | hsa04370 | VEGF signaling pathway | 4.83E-07 | 5 | P16298, P31751, Q05397, Q02750, P04049 | PPP3CB, AKT2, PTK2, MAP2K1, RAF1 | More | | Idelalisib | hsa04371 | Apelin signaling pathway | 1.43E-04 | 3 | P31751, P04049, P0DP23 | AKT2, RAF1, CALM1 | More | | Idelalisib | hsa04380 | Osteoclast differentiation | 2.72E-04 | 8 | Q9NQC7, Q9UQC2, Q16539, P31751, P14778, O75015, P01375, Q8N149 | CYLD, GAB2, MAPK14, AKT2, IL1R1, FCGR3B, TNF, LILRA2 | More | | Idelalisib | hsa04390 | Hippo signaling pathway | 5.79E-03 | 4 | P04628, Q9UJU2, O43623, Q13489 | WNT1, LEF1, SNAI2, BIRC3 | More | | Idelalisib | hsa04392 | Hippo signaling pathway - multiple species | 3.01E-02 | 1 | Q6V0I7 | FAT4 | More | | Idelalisib | hsa04510 | Focal adhesion | 1.18E-03 | 2 | P04049, P08069 | RAF1, IGF1R | More | | Idelalisib | hsa04520 | Adherens junction | 8.29E-03 | 1 | P08069 | IGF1R | More | | Idelalisib | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | | Idelalisib | hsa04540 | Gap junction | 1.05E-05 | 8 | P17252, P22694, Q13509, P68371, Q02750, P04049, Q9NRA1, Q14643 | PRKCA, PRKACB, TUBB3, TUBB2C, MAP2K1, RAF1, PDGFC, ITPR1 | More | | Idelalisib | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 3.80E-04 | 2 | P04049, P08069 | RAF1, IGF1R | More | | Idelalisib | hsa04610 | Complement and coagulation cascades | 5.97E-09 | 2 | P00734, P0C0L4 | F2, C4A | More | | Idelalisib | hsa04611 | Platelet activation | 2.12E-02 | 2 | Q9Y490, P17612 | TLN1, PRKACA | More | | Idelalisib | hsa04612 | Antigen processing and presentation | 3.15E-05 | 9 | P13765, P48382, P01730, P26715, P26717, Q13241, P01732, P11142, P01375 | HLA-DOB, RFX5, CD4, KLRC1, KLRC2, KLRD1, CD8A, HSPA8, TNF | More | | Idelalisib | hsa04613 | Neutrophil extracellular trap formation | 1.65E-06 | 15 | P19174, P17252, P04049, P11215, O60603, P08246, Q13547, Q6FI13, Q93077, P62807, O60814, P68431, P14598, Q15080, P21462 | PLCG1, PRKCA, RAF1, ITGAM, TLR2, ELA2, HDAC1, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF1, NCF4, FPR1 | More | | Idelalisib | hsa04620 | Toll-like receptor signaling pathway | 4.81E-03 | 3 | Q13546, P01568, P31751 | RIPK1, IFNA21, AKT2 | More | | Idelalisib | hsa04621 | NOD-like receptor signaling pathway | 4.72E-02 | 3 | P01568, Q13489, Q13546 | IFNA21, BIRC3, RIPK1 | More | | Idelalisib | hsa04622 | RIG-I-like receptor signaling pathway | 1.02E-03 | 3 | P01568, Q9NQC7, Q13546 | IFNA21, CYLD, RIPK1 | More | | Idelalisib | hsa04623 | Cytosolic DNA-sensing pathway | 9.08E-08 | 5 | P01584, P01568, Q13546, P25963, Q8NHW4 | IL1B, IFNA21, RIPK1, NFKBIA, CCL4L2 | More | | Idelalisib | hsa04625 | C-type lectin receptor signaling pathway | 2.59E-05 | 8 | Q9ULY5, P04049, Q9NQC7, P20749, P01375, P31751, P0DP23, Q16539 | CLEC4E, RAF1, CYLD, BCL3, TNF, AKT2, CALM1, MAPK14 | More | | Idelalisib | hsa04630 | JAK-STAT signaling pathway | 1.49E-02 | 1 | P04049 | RAF1 | More | | Idelalisib | hsa04640 | Hematopoietic cell lineage | 7.70E-07 | 14 | P13612, P14778, P27930, P11215, P15144, P25063, P07766, P09693, P01732, P01730, P06127, P09564, P13765, P01375 | ITGA4, IL1R1, IL1R2, ITGAM, ANPEP, CD24, CD3E, CD3G, CD8A, CD4, CD5, CD7, HLA-DOB, TNF | More | | Idelalisib | hsa04650 | Natural killer cell mediated cytotoxicity | 7.34E-10 | 19 | P16298, P50591, P19174, P01375, P06239, O60880, P20963, Q29983, P10321, P01889, P42338, Q02750, P04049, Q13241, P26718, O14931, O75015, P26717, P26715 | PPP3CB, TNFSF10, PLCG1, TNF, LCK, SH2D1A, CD247, MICA, HLA-C, HLA-B, PIK3CB, MAP2K1, RAF1, KLRD1, KLRK1, NCR3, FCGR3B, KLRC2, KLRC1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P11511 | CYP19A1 | Aromatase | P16298 | PPP3CB | Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform | 0.706 | P11511 | CYP19A1 | Aromatase | P50591 | TNFSF10 | Tumor necrosis factor ligand superfamily member 10 | 0.701 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.774 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P06239 | LCK | Tyrosine-protein kinase Lck | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.906 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.862 | Q13547 | HDAC1 | Histone deacetylase 1 | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.786 | P06239 | LCK | Tyrosine-protein kinase Lck | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.927 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.839 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P67870 | CSNK2B | Casein kinase II subunit beta | Q29983 | MICA | MHC class I polypeptide-related sequence A | 0.705 | P67870 | CSNK2B | Casein kinase II subunit beta | P10321 | HLA-C | HLA class I histocompatibility antigen, C alpha chain | 0.705 | P67870 | CSNK2B | Casein kinase II subunit beta | P01889 | HLA-B | HLA class I histocompatibility antigen, B alpha chain | 0.705 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | P11511 | CYP19A1 | Aromatase | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 0.783 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P06239 | LCK | Tyrosine-protein kinase Lck | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.758 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.852 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.807 | P06239 | LCK | Tyrosine-protein kinase Lck | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.886 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.922 | Q13547 | HDAC1 | Histone deacetylase 1 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.772 | P06239 | LCK | Tyrosine-protein kinase Lck | O14931 | NCR3 | Natural cytotoxicity triggering receptor 3 | 0.732 | Q13547 | HDAC1 | Histone deacetylase 1 | O14931 | NCR3 | Natural cytotoxicity triggering receptor 3 | 0.735 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | -0.778 | P06239 | LCK | Tyrosine-protein kinase Lck | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.756 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.943 | P06239 | LCK | Tyrosine-protein kinase Lck | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.756 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.943 |
| Idelalisib | hsa04657 | IL-17 signaling pathway | 1.11E-05 | 11 | P25963, P08238, O00463, Q07955, Q16539, P49841, P09341, P14780, P04141, P01375, P06702 | NFKBIA, HSP90AB1, TRAF5, SFRS1, MAPK14, GSK3B, CXCL1, MMP9, CSF2, TNF, S100A9 | More | | Idelalisib | hsa04658 | Th1 and Th2 cell differentiation | 3.59E-13 | 16 | P25963, Q04759, P07766, P20963, P09693, P19174, P01730, P06239, P42224, Q14765, P23771, Q9UL17, P14784, Q9UM47, P13765, Q13761 | NFKBIA, PRKCQ, CD3E, CD247, CD3G, PLCG1, CD4, LCK, STAT1, STAT4, GATA3, TBX21, IL2RB, NOTCH3, HLA-DOB, RUNX3 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.734 | P06239 | LCK | Tyrosine-protein kinase Lck | Q04759 | PRKCQ | Protein kinase C theta type | 0.779 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q04759 | PRKCQ | Protein kinase C theta type | 0.803 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P07948 | LYN | Tyrosine-protein kinase Lyn | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.824 | P06239 | LCK | Tyrosine-protein kinase Lck | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.928 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P06239 | LCK | Tyrosine-protein kinase Lck | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.927 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.839 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P06239 | LCK | Tyrosine-protein kinase Lck | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.752 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.813 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.851 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P06239 | LCK | Tyrosine-protein kinase Lck | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | P07948 | LYN | Tyrosine-protein kinase Lyn | P06239 | LCK | Tyrosine-protein kinase Lck | -0.701 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.774 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 1 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.904 | P06239 | LCK | Tyrosine-protein kinase Lck | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.77 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.784 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.719 | P06239 | LCK | Tyrosine-protein kinase Lck | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.866 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.884 | Q13547 | HDAC1 | Histone deacetylase 1 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.817 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.732 | P07948 | LYN | Tyrosine-protein kinase Lyn | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.771 | P06239 | LCK | Tyrosine-protein kinase Lck | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.727 | Q13547 | HDAC1 | Histone deacetylase 1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.816 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | Q9UM47 | NOTCH3 | Neurogenic locus notch homolog protein 3 | 0.714 | P06239 | LCK | Tyrosine-protein kinase Lck | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.777 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.85 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q13761 | RUNX3 | Runt-related transcription factor 3 | -0.855 | P06239 | LCK | Tyrosine-protein kinase Lck | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.85 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.884 |
| Idelalisib | hsa04659 | Th17 cell differentiation | 3.30E-11 | 17 | P25963, Q04759, P19174, P01730, P06239, P42224, P14784, P13765, P14778, Q9HBE5, Q9UL17, P23771, Q13485, P08238, P07766, P09693, P20963 | NFKBIA, PRKCQ, PLCG1, CD4, LCK, STAT1, IL2RB, HLA-DOB, IL1R1, IL21R, TBX21, GATA3, SMAD4, HSP90AB1, CD3E, CD3G, CD247 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.734 | P06239 | LCK | Tyrosine-protein kinase Lck | Q04759 | PRKCQ | Protein kinase C theta type | 0.779 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q04759 | PRKCQ | Protein kinase C theta type | 0.803 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.851 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P06239 | LCK | Tyrosine-protein kinase Lck | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | P07948 | LYN | Tyrosine-protein kinase Lyn | P06239 | LCK | Tyrosine-protein kinase Lck | -0.701 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.774 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 1 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.732 | P07948 | LYN | Tyrosine-protein kinase Lyn | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.771 | P06239 | LCK | Tyrosine-protein kinase Lck | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.727 | Q13547 | HDAC1 | Histone deacetylase 1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.816 | P06239 | LCK | Tyrosine-protein kinase Lck | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.777 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.85 | P07948 | LYN | Tyrosine-protein kinase Lyn | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.714 | P06239 | LCK | Tyrosine-protein kinase Lck | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.782 | Q13547 | HDAC1 | Histone deacetylase 1 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.854 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9HBE5 | IL21R | Interleukin-21 receptor | 0.713 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.719 | P06239 | LCK | Tyrosine-protein kinase Lck | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.866 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.884 | Q13547 | HDAC1 | Histone deacetylase 1 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.817 | P06239 | LCK | Tyrosine-protein kinase Lck | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.77 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.784 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.729 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.783 | P07948 | LYN | Tyrosine-protein kinase Lyn | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.782 | P07948 | LYN | Tyrosine-protein kinase Lyn | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.824 | P06239 | LCK | Tyrosine-protein kinase Lck | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.928 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P06239 | LCK | Tyrosine-protein kinase Lck | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.752 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.813 | P06239 | LCK | Tyrosine-protein kinase Lck | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.927 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.839 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 |
| Idelalisib | hsa04660 | T cell receptor signaling pathway | 2.07E-09 | 20 | P01375, P04141, P25963, Q9UDY8, Q04759, P42338, P10747, O95267, Q08881, P19174, P16333, P07766, P20963, P09693, P01730, P01732, Q13191, P06239, P29350, P04049 | TNF, CSF2, NFKBIA, MALT1, PRKCQ, PIK3CB, CD28, RASGRP1, ITK, PLCG1, NCK1, CD3E, CD247, CD3G, CD4, CD8A, CBLB, LCK, PTPN6, RAF1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P04141 | CSF2 | Granulocyte-macrophage colony-stimulating factor | 0.757 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | -0.739 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.721 | P06239 | LCK | Tyrosine-protein kinase Lck | Q04759 | PRKCQ | Protein kinase C theta type | 0.779 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q04759 | PRKCQ | Protein kinase C theta type | 0.803 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | 0.758 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | 0.925 | P06239 | LCK | Tyrosine-protein kinase Lck | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.774 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 1 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.739 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P16333 | NCK1 | Cytoplasmic protein NCK1 | -0.703 | P06239 | LCK | Tyrosine-protein kinase Lck | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.928 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P06239 | LCK | Tyrosine-protein kinase Lck | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.927 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.839 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P06239 | LCK | Tyrosine-protein kinase Lck | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.752 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.813 | P06239 | LCK | Tyrosine-protein kinase Lck | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | P06239 | LCK | Tyrosine-protein kinase Lck | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.841 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.803 | Q13547 | HDAC1 | Histone deacetylase 1 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.816 | P06239 | LCK | Tyrosine-protein kinase Lck | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.714 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.811 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.806 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.774 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | -0.797 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 |
| Idelalisib | hsa04662 | B cell receptor signaling pathway | 3.15E-06 | 7 | P31751, P42338, P60033, P07948, P21854, Q8N149, P04049 | AKT2, PIK3CB, CD81, LYN, CD72, LILRA2, RAF1 | More | | Idelalisib | hsa04664 | Fc epsilon RI signaling pathway | 3.97E-06 | 9 | P01375, P31751, Q16539, P42338, Q9UQC2, P07948, P04049, P09917, P20292 | TNF, AKT2, MAPK14, PIK3CB, GAB2, LYN, RAF1, ALOX5, ALOX5AP | More | | Idelalisib | hsa04666 | Fc gamma R-mediated phagocytosis | 2.32E-02 | 1 | P04049 | RAF1 | More | | Idelalisib | hsa04668 | TNF signaling pathway | 2.21E-02 | 5 | P01375, O00463, Q16539, P20749, P14780 | TNF, TRAF5, MAPK14, BCL3, MMP9 | More | | Idelalisib | hsa04672 | Intestinal immune network for IgA production | 3.76E-03 | 3 | P29965, P10747, P13765 | CD40LG, CD28, HLA-DOB | More | | Idelalisib | hsa04710 | Circadian rhythm | 3.74E-03 | 2 | O00327, O15055 | ARNTL, PER2 | More | | Idelalisib | hsa04713 | Circadian entrainment | 2.17E-03 | 5 | P0DP23, P17252, P62873, Q14643, O15055 | CALM1, PRKCA, GNB1, ITPR1, PER2 | More | | Idelalisib | hsa04714 | Thermogenesis | 3.31E-02 | 4 | P51828, P62753, P12074, O15239 | ADCY7, RPS6, COX6A1, NDUFA1 | More | | Idelalisib | hsa04720 | Long-term potentiation | 2.05E-08 | 11 | P17252, P16298, P0DP23, Q15418, P51812, P18848, P17612, P22694, Q02750, P04049, Q14643 | PRKCA, PPP3CB, CALM1, RPS6KA1, RPS6KA3, ATF4, PRKACA, PRKACB, MAP2K1, RAF1, ITPR1 | More | | Idelalisib | hsa04721 | Synaptic vesicle cycle | 1.80E-02 | 2 | Q13488, P31645 | TCIRG1, SLC6A4 | More | | Idelalisib | hsa04722 | Neurotrophin signaling pathway | 3.42E-05 | 8 | P31751, P04049, P49841, O43524, P48023, P51617, P10415, P0DP23 | AKT2, RAF1, GSK3B, FOXO3, FASLG, IRAK1, BCL2, CALM1 | More | | Idelalisib | hsa04723 | Retrograde endocannabinoid signaling | 1.43E-03 | 6 | Q14643, P17252, P48169, P62873, P17612, Q16718 | ITPR1, PRKCA, GABRA4, GNB1, PRKACA, NDUFA5 | More | | Idelalisib | hsa04724 | Glutamatergic synapse | 3.88E-04 | 4 | O15399, P63218, P50151, P15104 | GRIN2D, GNG5, GNG10, GLUL | More | | Idelalisib | hsa04725 | Cholinergic synapse | 2.70E-07 | 14 | P51828, P17612, P22694, Q14643, P17252, P62873, P62879, P63218, P50151, P18848, Q13557, P42338, P10415, Q02750 | ADCY7, PRKACA, PRKACB, ITPR1, PRKCA, GNB1, GNB2, GNG5, GNG10, ATF4, CAMK2D, PIK3CB, BCL2, MAP2K1 | More | | Idelalisib | hsa04726 | Serotonergic synapse | 4.46E-03 | 5 | P22694, P17252, P62879, P04049, Q02750 | PRKACB, PRKCA, GNB2, RAF1, MAP2K1 | More | | Idelalisib | hsa04727 | GABAergic synapse | 2.27E-05 | 10 | P62873, P62879, P63218, P50151, P48169, P15104, P17612, P22694, O60296, P17252 | GNB1, GNB2, GNG5, GNG10, GABRA4, GLUL, PRKACA, PRKACB, TRAK2, PRKCA | More | | Idelalisib | hsa04728 | Dopaminergic synapse | 1.80E-05 | 11 | P17612, Q14643, P17252, P62873, P31751, Q99941, P18848, Q13557, Q13362, P0DP23, O15516 | PRKACA, ITPR1, PRKCA, GNB1, AKT2, CREBL1, ATF4, CAMK2D, PPP2R5C, CALM1, CLOCK | More | | Idelalisib | hsa04730 | Long-term depression | 1.25E-04 | 2 | P08069, P04049 | IGF1R, RAF1 | More | | Idelalisib | hsa04740 | Olfactory transduction | 8.48E-05 | 3 | P62873, P0DP23, P17612 | GNB1, CALM1, PRKACA | More | | Idelalisib | hsa04742 | Taste transduction | 2.53E-04 | 2 | P48169, P17612 | GABRA4, PRKACA | More | | Idelalisib | hsa04744 | Phototransduction | 3.25E-09 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Idelalisib | hsa04750 | Inflammatory mediator regulation of TRP channels | 7.85E-04 | 9 | P14778, P01584, Q08828, P51828, P19174, P42338, P24723, Q04759, P0DP23 | IL1R1, IL1B, ADCY1, ADCY7, PLCG1, PIK3CB, PRKCH, PRKCQ, CALM1 | More | | Idelalisib | hsa04810 | Regulation of actin cytoskeleton | 3.81E-02 | 1 | P04049 | RAF1 | More | | Idelalisib | hsa04910 | Insulin signaling pathway | 1.27E-05 | 6 | Q14642, P0DP23, P04049, P31751, Q13191, Q9Y4H2 | INPP5A, CALM1, RAF1, AKT2, CBLB, IRS2 | More | | Idelalisib | hsa04911 | Insulin secretion | 4.03E-04 | 4 | P51828, Q99941, P18848, Q13557 | ADCY7, CREBL1, ATF4, CAMK2D | More | | Idelalisib | hsa04912 | GnRH signaling pathway | 1.31E-03 | 7 | P17252, P51828, P18848, Q13557, Q14643, P0DP23, P04049 | PRKCA, ADCY7, ATF4, CAMK2D, ITPR1, CALM1, RAF1 | More | | Idelalisib | hsa04913 | Ovarian steroidogenesis | 1.16E-02 | 1 | P08069 | IGF1R | More | | Idelalisib | hsa04914 | Progesterone-mediated oocyte maturation | 7.06E-05 | 6 | P08069, Q17RY0, Q9Y6D9, P51812, Q02750, P04049 | IGF1R, CPEB4, MAD1L1, RPS6KA3, MAP2K1, RAF1 | More | | Idelalisib | hsa04915 | Estrogen signaling pathway | 8.72E-06 | 15 | P14780, P22694, P04049, Q99941, P18848, Q08828, P51828, P31751, P07900, P0DMV8, P11142, Q14643, P0DP23, Q15788, P10415 | MMP9, PRKACB, RAF1, CREBL1, ATF4, ADCY1, ADCY7, AKT2, HSP90AA1, HSPA1A, HSPA8, ITPR1, CALM1, NCOA1, BCL2 | More | | Idelalisib | hsa04916 | Melanogenesis | 1.47E-03 | 2 | P0DP23, P04049 | CALM1, RAF1 | More | | Idelalisib | hsa04917 | Prolactin signaling pathway | 3.49E-04 | 2 | P31751, P04049 | AKT2, RAF1 | More | | Idelalisib | hsa04918 | Thyroid hormone synthesis | 1.47E-04 | 7 | P22694, P51828, Q99941, P18848, Q14643, P02768, P05543 | PRKACB, ADCY7, CREBL1, ATF4, ITPR1, ALB, SERPINA7 | More | | Idelalisib | hsa04919 | Thyroid hormone signaling pathway | 4.56E-03 | 6 | P17252, P04049, Q02750, P22694, Q12778, Q9UM47 | PRKCA, RAF1, MAP2K1, PRKACB, FOXO1, NOTCH3 | More | | Idelalisib | hsa04920 | Adipocytokine signaling pathway | 4.19E-02 | 1 | P31751 | AKT2 | More | | Idelalisib | hsa04921 | Oxytocin signaling pathway | 2.32E-02 | 1 | P04049 | RAF1 | More | | Idelalisib | hsa04922 | Glucagon signaling pathway | 2.33E-03 | 5 | Q12778, P31751, Q13370, P0DP23, Q14643 | FOXO1, AKT2, PDE3B, CALM1, ITPR1 | More | | Idelalisib | hsa04923 | Regulation of lipolysis in adipocytes | 3.88E-03 | 4 | P07550, P42338, Q9Y4H2, P31751 | ADRB2, PIK3CB, IRS2, AKT2 | More | | Idelalisib | hsa04924 | Renin secretion | 1.70E-03 | 3 | Q14643, Q13370, P0DP23 | ITPR1, PDE3B, CALM1 | More | | Idelalisib | hsa04925 | Aldosterone synthesis and secretion | 1.69E-03 | 4 | Q99941, P18848, P51828, Q13557 | CREBL1, ATF4, ADCY7, CAMK2D | More | | Idelalisib | hsa04926 | Relaxin signaling pathway | 1.38E-04 | 9 | P42338, P63218, P50151, Q99941, P18848, P49767, P51828, P04049, P49407 | PIK3CB, GNG5, GNG10, CREBL1, ATF4, VEGFC, ADCY7, RAF1, ARRB1 | More | | Idelalisib | hsa04927 | Cortisol synthesis and secretion | 2.37E-04 | 5 | Q14643, Q99941, P18848, P51828, P22694 | ITPR1, CREBL1, ATF4, ADCY7, PRKACB | More | | Idelalisib | hsa04928 | Parathyroid hormone synthesis, secretion and action | 9.81E-05 | 11 | Q14643, P51828, P22694, P23771, P04049, Q02750, P17252, Q99941, P18848, P10415, Q9Y5Q3 | ITPR1, ADCY7, PRKACB, GATA3, RAF1, MAP2K1, PRKCA, CREBL1, ATF4, BCL2, MAFB | More | | Idelalisib | hsa04929 | GnRH secretion | 2.28E-04 | 4 | P42338, P31751, P49407, P04049 | PIK3CB, AKT2, ARRB1, RAF1 | More | | Idelalisib | hsa04932 | Non-alcoholic fatty liver disease | 7.56E-04 | 9 | P01375, P49841, O43521, P48023, O75460, P01584, P13073, P12074, O95298 | TNF, GSK3B, BCL2L11, FASLG, ERN1, IL1B, COX4I1, COX6A1, NDUFC2 | More | | Idelalisib | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 6.00E-04 | 6 | P42224, P10415, Q12778, P49767, P17252, P19174 | STAT1, BCL2, FOXO1, VEGFC, PRKCA, PLCG1 | More | | Idelalisib | hsa04934 | Cushing syndrome | 6.81E-05 | 6 | Q99941, P18848, P51828, P17612, O15169, Q13557 | CREBL1, ATF4, ADCY7, PRKACA, AXIN1, CAMK2D | More | | Idelalisib | hsa04935 | Growth hormone synthesis, secretion and action | 5.33E-03 | 4 | P51828, P04049, Q99941, P18848 | ADCY7, RAF1, CREBL1, ATF4 | More | | Idelalisib | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Idelalisib | hsa04962 | Vasopressin-regulated water reabsorption | 7.22E-03 | 2 | P52566, P62491 | ARHGDIB, RAB11A | More | | Idelalisib | hsa04964 | Proximal tubule bicarbonate reclamation | 2.17E-03 | 1 | P00918 | CA2 | More | | Idelalisib | hsa04966 | Collecting duct acid secretion | 1.26E-04 | 3 | Q13488, P00918, Q9Y666 | TCIRG1, CA2, SLC12A7 | More | | Idelalisib | hsa04970 | Salivary secretion | 1.22E-03 | 6 | Q08828, P51828, P22694, P17252, P0DP23, P49913 | ADCY1, ADCY7, PRKACB, PRKCA, CALM1, CAMP | More | | Idelalisib | hsa04971 | Gastric acid secretion | 4.78E-02 | 1 | P0DP23 | CALM1 | More | | Idelalisib | hsa04972 | Pancreatic secretion | 1.31E-02 | 2 | Q08828, P62491 | ADCY1, RAB11A | More | | Idelalisib | hsa04973 | Carbohydrate digestion and absorption | 4.61E-03 | 3 | O43451, P42338, P31751 | MGAM, PIK3CB, AKT2 | More | | Idelalisib | hsa04975 | Fat digestion and absorption | 1.43E-03 | 1 | O14494 | PLPP1 | More | | Idelalisib | hsa04976 | Bile secretion | 4.78E-02 | 3 | Q08828, P51828, Q14032 | ADCY1, ADCY7, BAAT | More | | Idelalisib | hsa05010 | Alzheimer disease | 3.97E-05 | 16 | Q16718, O14521, P13073, Q14643, Q00535, P0DP23, P18848, Q13509, P68371, O15169, P67870, P31751, P05141, P12236, Q08752, P28070 | NDUFA5, SDHD, COX4I1, ITPR1, CDK5, CALM1, ATF4, TUBB3, TUBB2C, AXIN1, CSNK2B, AKT2, SLC25A5, SLC25A6, PPID, PSMB4 | More | | Idelalisib | hsa05012 | Parkinson disease | 2.02E-04 | 13 | Q16718, O14521, P13073, P05141, P12236, P17612, P18848, P28070, Q14643, P19174, P0DP23, Q13509, P68371 | NDUFA5, SDHD, COX4I1, SLC25A5, SLC25A6, PRKACA, ATF4, PSMB4, ITPR1, PLCG1, CALM1, TUBB3, TUBB2C | More | | Idelalisib | hsa05016 | Huntington disease | 2.46E-02 | 9 | O95298, P13073, P12074, P24928, P30876, P62487, O75460, P28070, O00232 | NDUFC2, COX4I1, COX6A1, POLR2A, POLR2B, POLR2G, ERN1, PSMB4, PSMD12 | More | | Idelalisib | hsa05017 | Spinocerebellar ataxia | 2.22E-02 | 4 | Q92915, O15399, P42338, P21796 | FGF14, GRIN2D, PIK3CB, VDAC1 | More | | Idelalisib | hsa05020 | Prion disease | 1.63E-04 | 14 | P17612, Q16718, O14521, P13073, Q14643, P18848, P05141, P12236, P28070, Q13509, P68371, P67870, P14598, Q15080 | PRKACA, NDUFA5, SDHD, COX4I1, ITPR1, ATF4, SLC25A5, SLC25A6, PSMB4, TUBB3, TUBB2C, CSNK2B, NCF1, NCF4 | More | | Idelalisib | hsa05022 | Pathways of neurodegeneration - multiple diseases | 2.65E-05 | 21 | Q14643, Q13509, P68371, P67870, P10415, Q16718, O14521, P13073, Q06055, P18848, Q13561, P19174, P05141, P12236, P17252, Q00535, O15169, Q08752, O15020, P0DP23, P28070 | ITPR1, TUBB3, TUBB2C, CSNK2B, BCL2, NDUFA5, SDHD, COX4I1, ATP5G2, ATF4, DCTN2, PLCG1, SLC25A5, SLC25A6, PRKCA, CDK5, AXIN1, PPID, SPTBN2, CALM1, PSMB4 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P17252 | PRKCA | Protein kinase C alpha type | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.786 | P17252 | PRKCA | Protein kinase C alpha type | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.756 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.808 | P17252 | PRKCA | Protein kinase C alpha type | P68371 | TUBB2C | Tubulin beta-4B chain | -0.842 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P68371 | TUBB2C | Tubulin beta-4B chain | -0.721 | P67870 | CSNK2B | Casein kinase II subunit beta | P67870 | CSNK2B | Casein kinase II subunit beta | 1 | P17252 | PRKCA | Protein kinase C alpha type | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.844 | P17252 | PRKCA | Protein kinase C alpha type | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.811 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.812 | P17252 | PRKCA | Protein kinase C alpha type | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.822 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.712 | P67870 | CSNK2B | Casein kinase II subunit beta | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.784 | P30530 | AXL | Tyrosine-protein kinase receptor UFO | Q06055 | ATP5G2 | ATP synthase F(0) complex subunit C2, mitochondrial | -0.735 | P67870 | CSNK2B | Casein kinase II subunit beta | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.733 | P17252 | PRKCA | Protein kinase C alpha type | Q13561 | DCTN2 | Dynactin subunit 2 | -0.844 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q13561 | DCTN2 | Dynactin subunit 2 | -0.744 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.739 | P67870 | CSNK2B | Casein kinase II subunit beta | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.797 | P67870 | CSNK2B | Casein kinase II subunit beta | P12236 | SLC25A6 | ADP/ATP translocase 3 | 0.715 | P17252 | PRKCA | Protein kinase C alpha type | P17252 | PRKCA | Protein kinase C alpha type | 1 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P17252 | PRKCA | Protein kinase C alpha type | 0.832 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | 0.726 | P67870 | CSNK2B | Casein kinase II subunit beta | O15169 | AXIN1 | Axin-1 | 0.702 | P17252 | PRKCA | Protein kinase C alpha type | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | 0.725 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | 0.728 | P30530 | AXL | Tyrosine-protein kinase receptor UFO | O15020 | SPTBN2 | Spectrin beta chain, non-erythrocytic 2 | 0.738 | P17252 | PRKCA | Protein kinase C alpha type | P0DP23 | CALM1 | Calmodulin-1 | -0.776 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P0DP23 | CALM1 | Calmodulin-1 | -0.761 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P0DP23 | CALM1 | Calmodulin-1 | 0.761 | P67870 | CSNK2B | Casein kinase II subunit beta | P28070 | PSMB4 | Proteasome subunit beta type-4 | 0.734 |
| Idelalisib | hsa05030 | Cocaine addiction | 6.96E-03 | 3 | Q00535, Q99941, P18848 | CDK5, CREBL1, ATF4 | More | | Idelalisib | hsa05031 | Amphetamine addiction | 9.24E-04 | 4 | P0DP23, Q13557, Q99941, P18848 | CALM1, CAMK2D, CREBL1, ATF4 | More | | Idelalisib | hsa05032 | Morphine addiction | 1.01E-02 | 3 | P17612, P62873, P48169 | PRKACA, GNB1, GABRA4 | More | | Idelalisib | hsa05034 | Alcoholism | 4.09E-07 | 11 | P17612, P18848, P0DP23, Q96RR4, P62873, P04049, Q93077, P62807, O60814, P84243, P68431 | PRKACA, ATF4, CALM1, CAMKK2, GNB1, RAF1, HIST1H2AC, HIST1H2BC, H2BC12, H3F3A, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Idelalisib | hsa05110 | Vibrio cholerae infection | 1.35E-06 | 5 | Q13488, Q99437, P17252, P19174, P17612 | TCIRG1, ATP6V0B, PRKCA, PLCG1, PRKACA | More | | Idelalisib | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 1.96E-04 | 6 | Q16539, P09341, P19875, P19174, P25024, P25025 | MAPK14, CXCL1, CXCL2, PLCG1, CXCR1, CXCR2 | More | | Idelalisib | hsa05130 | Pathogenic Escherichia coli infection | 4.08E-02 | 3 | Q15438, P35579, P55061 | PSCD1, MYH9, TEGT | More | | Idelalisib | hsa05131 | Shigellosis | 2.27E-02 | 8 | P68431, Q9UDY8, Q14247, Q14643, Q12778, Q13315, P10415, Q08752 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, MALT1, CTTN, ITPR1, FOXO1, ATM, BCL2, PPID | More | | Idelalisib | hsa05132 | Salmonella infection | 5.06E-09 | 17 | P51617, P25963, P08238, P04049, Q9UJU2, Q13546, Q13489, P10415, P04406, O75369, O60603, Q9BQS8, Q13561, O60282, Q13509, P68371, P49754 | IRAK1, NFKBIA, HSP90AB1, RAF1, LEF1, RIPK1, BIRC3, BCL2, GAPDH, FLNB, TLR2, FYCO1, DCTN2, KIF5C, TUBB3, TUBB2C, VPS41 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | 1 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | -0.739 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.826 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | Q9UJU2 | LEF1 | Lymphoid enhancer-binding factor 1 | -0.72 | P17252 | PRKCA | Protein kinase C alpha type | Q9UJU2 | LEF1 | Lymphoid enhancer-binding factor 1 | 0.881 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | Q9UJU2 | LEF1 | Lymphoid enhancer-binding factor 1 | 0.768 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | 1 | P08235 | NR3C2 | Mineralocorticoid receptor | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | -0.749 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.788 | P17252 | PRKCA | Protein kinase C alpha type | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.849 | P08235 | NR3C2 | Mineralocorticoid receptor | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.868 | P17252 | PRKCA | Protein kinase C alpha type | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.844 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.807 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P04406 | GAPDH | Glyceraldehyde-3-phosphate dehydrogenase | -0.76 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | O75369 | FLNB | Filamin-B | -0.715 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | O75369 | FLNB | Filamin-B | -0.713 | P17252 | PRKCA | Protein kinase C alpha type | O60603 | TLR2 | Toll-like receptor 2 | -0.716 | P17252 | PRKCA | Protein kinase C alpha type | Q9BQS8 | FYCO1 | FYVE and coiled-coil domain-containing protein 1 | 0.701 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | Q9BQS8 | FYCO1 | FYVE and coiled-coil domain-containing protein 1 | 0.812 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | Q13561 | DCTN2 | Dynactin subunit 2 | 0.754 | P17252 | PRKCA | Protein kinase C alpha type | Q13561 | DCTN2 | Dynactin subunit 2 | -0.844 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q13561 | DCTN2 | Dynactin subunit 2 | -0.744 | P08235 | NR3C2 | Mineralocorticoid receptor | O60282 | KIF5C | Kinesin heavy chain isoform 5C | 0.753 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | Q13509 | TUBB3 | Tubulin beta-3 chain | 0.735 | P17252 | PRKCA | Protein kinase C alpha type | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.756 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.808 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.757 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | P68371 | TUBB2C | Tubulin beta-4B chain | 0.748 | P17252 | PRKCA | Protein kinase C alpha type | P68371 | TUBB2C | Tubulin beta-4B chain | -0.842 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P68371 | TUBB2C | Tubulin beta-4B chain | -0.721 | P08235 | NR3C2 | Mineralocorticoid receptor | P68371 | TUBB2C | Tubulin beta-4B chain | -0.747 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P49754 | VPS41 | Vacuolar protein sorting-associated protein 41 homolog | -0.718 |
| Idelalisib | hsa05133 | Pertussis | 2.60E-04 | 2 | P0DP23, P0C0L4 | CALM1, C4A | More | | Idelalisib | hsa05134 | Legionellosis | 1.51E-05 | 7 | P01584, Q9NR31, P11215, P0DMV8, P11142, P09341, P19875 | IL1B, SAR1A, ITGAM, HSPA1A, HSPA8, CXCL1, CXCL2 | More | | Idelalisib | hsa05140 | Leishmaniasis | 1.39E-09 | 13 | P13612, O75015, P14598, P11215, P42224, P13765, O60603, P25963, P01375, P29350, P49006, Q16539, Q15080 | ITGA4, FCGR3B, NCF1, ITGAM, STAT1, HLA-DOB, TLR2, NFKBIA, TNF, PTPN6, MARCKSL1, MAPK14, NCF4 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P13612 | ITGA4 | Integrin alpha-4 | 0.774 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.814 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | -0.778 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.801 | P17252 | PRKCA | Protein kinase C alpha type | P14598 | NCF1 | Neutrophil cytosol factor 1 | -0.821 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P14598 | NCF1 | Neutrophil cytosol factor 1 | -0.867 | P49336 | CDK8 | Cyclin-dependent kinase 8 | P14598 | NCF1 | Neutrophil cytosol factor 1 | -0.721 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P11215 | ITGAM | Integrin alpha-M | -0.844 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 1 | P17252 | PRKCA | Protein kinase C alpha type | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.706 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.912 | P17252 | PRKCA | Protein kinase C alpha type | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.709 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.754 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.85 | P17252 | PRKCA | Protein kinase C alpha type | O60603 | TLR2 | Toll-like receptor 2 | -0.716 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O60603 | TLR2 | Toll-like receptor 2 | 0.73 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O60603 | TLR2 | Toll-like receptor 2 | -0.714 | P49336 | CDK8 | Cyclin-dependent kinase 8 | O60603 | TLR2 | Toll-like receptor 2 | -0.734 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.734 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | -0.739 | P49336 | CDK8 | Cyclin-dependent kinase 8 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | -0.728 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | 0.81 | P17252 | PRKCA | Protein kinase C alpha type | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | -0.754 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | -0.797 | P49336 | CDK8 | Cyclin-dependent kinase 8 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | -0.726 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P49006 | MARCKSL1 | MARCKS-related protein | -0.852 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 1 | P17252 | PRKCA | Protein kinase C alpha type | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.836 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.723 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.74 | P49336 | CDK8 | Cyclin-dependent kinase 8 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.754 |
| Idelalisib | hsa05143 | African trypanosomiasis | 8.39E-06 | 4 | P01375, P69905, P68871, P48023 | TNF, HBA2, HBB, FASLG | More | | Idelalisib | hsa05144 | Malaria | 1.53E-03 | 7 | P60033, P69905, P68871, O60603, P01375, P35443, P26718 | CD81, HBA2, HBB, TLR2, TNF, THBS4, KLRK1 | More | | Idelalisib | hsa05145 | Toxoplasmosis | 1.11E-02 | 6 | P10415, Q13489, P42224, P13765, O60603, P29965 | BCL2, BIRC3, STAT1, HLA-DOB, TLR2, CD40LG | More | | Idelalisib | hsa05146 | Amoebiasis | 1.62E-07 | 12 | P09341, P19875, P14778, P27930, P01375, O60603, P42338, P11215, P05089, P22694, P12814, P08311 | CXCL1, CXCL2, IL1R1, IL1R2, TNF, TLR2, PIK3CB, ITGAM, ARG1, PRKACB, ACTN1, CTSG | More | | Idelalisib | hsa05150 | Staphylococcus aureus infection | 1.16E-03 | 6 | P0C0L4, P13646, Q14532, P59665, P59666, P49913 | C4A, KRT13, KRT32, DEFA1; DEFA1B, DEFA3, CAMP | More | | Idelalisib | hsa05152 | Tuberculosis | 4.74E-07 | 14 | P04049, Q13488, Q99437, P0DP23, P42224, P48382, O60603, P31751, P10415, P13765, P25774, P01568, Q9UDY8, P51617 | RAF1, TCIRG1, ATP6V0B, CALM1, STAT1, RFX5, TLR2, AKT2, BCL2, HLA-DOB, CTSS, IFNA21, MALT1, IRAK1 | More | | Idelalisib | hsa05160 | Hepatitis C | 1.40E-03 | 5 | P60033, P04049, P49841, P01375, P48023 | CD81, RAF1, GSK3B, TNF, FASLG | More | | Idelalisib | hsa05161 | Hepatitis B | 5.33E-03 | 4 | P04049, Q99941, P18848, P27348 | RAF1, CREBL1, ATF4, YWHAQ | More | | Idelalisib | hsa05162 | Measles | 3.18E-02 | 4 | P23458, P0DMV8, P01584, Q9NP90 | JAK1, HSPA1A, IL1B, RAB9B | More | | Idelalisib | hsa05163 | Human cytomegalovirus infection | 1.52E-05 | 22 | P31751, P04049, P01375, P01889, P10321, P62873, Q14643, P0DP23, Q8NHW4, Q08828, P51828, P17612, P23458, P49841, P14778, P01584, Q13651, P25025, Q16539, P18848, P04637, O00463 | AKT2, RAF1, TNF, HLA-B, HLA-C, GNB1, ITPR1, CALM1, CCL4L2, ADCY1, ADCY7, PRKACA, JAK1, GSK3B, IL1R1, IL1B, IL10RA, CXCR2, MAPK14, ATF4, TP53, TRAF5 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 1 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P01375 | TNF | Tumor necrosis factor | 0.732 | P67870 | CSNK2B | Casein kinase II subunit beta | P01889 | HLA-B | HLA class I histocompatibility antigen, B alpha chain | 0.705 | P67870 | CSNK2B | Casein kinase II subunit beta | P10321 | HLA-C | HLA class I histocompatibility antigen, C alpha chain | 0.705 | P67870 | CSNK2B | Casein kinase II subunit beta | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.704 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | -0.728 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P0DP23 | CALM1 | Calmodulin-1 | 0.822 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P0DP23 | CALM1 | Calmodulin-1 | 0.761 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.802 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.802 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.84 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.834 | P67870 | CSNK2B | Casein kinase II subunit beta | P17612 | PRKACA | cAMP-dependent protein kinase catalytic subunit alpha | 0.75 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.78 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.76 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.778 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P01584 | IL1B | Interleukin-1 beta | 0.799 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | 0.799 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.889 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.861 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 1 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.78 | P67870 | CSNK2B | Casein kinase II subunit beta | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.733 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P04637 | TP53 | Cellular tumor antigen p53 | -0.823 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.837 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.734 |
| Idelalisib | hsa05164 | Influenza A | 3.65E-02 | 1 | P04049 | RAF1 | More | | Idelalisib | hsa05165 | Human papillomavirus infection | 5.80E-04 | 14 | P46527, Q02750, P16144, P35443, Q92796, Q05086, Q9UM47, P01568, P42224, Q13488, P22694, Q13362, Q12778, Q13315 | CDKN1B, MAP2K1, ITGB4, THBS4, DLG3, UBE3A, NOTCH3, IFNA21, STAT1, TCIRG1, PRKACB, PPP2R5C, FOXO1, ATM | More | | Idelalisib | hsa05166 | Human T-cell leukemia virus 1 infection | 7.39E-03 | 7 | Q9Y490, P01889, P10321, P05141, P12236, P17612, P18848 | TLN1, HLA-B, HLA-C, SLC25A5, SLC25A6, PRKACA, ATF4 | More | | Idelalisib | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 3.00E-08 | 19 | P01568, P31751, P42224, P25963, P40189, P01889, P10321, P62873, P62879, P19174, P16298, Q14643, P04049, Q02750, Q29983, P04141, P0DP23, P0CG47, Q9UJU2 | IFNA21, AKT2, STAT1, NFKBIA, IL6ST, HLA-B, HLA-C, GNB1, GNB2, PLCG1, PPP3CB, ITPR1, RAF1, MAP2K1, MICA, CSF2, CALM1, UBB, LEF1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P17252 | PRKCA | Protein kinase C alpha type | P01568 | IFNA21 | Interferon alpha-21 | 0.733 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P01568 | IFNA21 | Interferon alpha-21 | 0.729 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 1 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 1 | P17252 | PRKCA | Protein kinase C alpha type | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.706 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.912 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.734 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | -0.739 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P40189 | IL6ST | Interleukin-6 receptor subunit beta | -0.746 | P67870 | CSNK2B | Casein kinase II subunit beta | P01889 | HLA-B | HLA class I histocompatibility antigen, B alpha chain | 0.705 | P67870 | CSNK2B | Casein kinase II subunit beta | P10321 | HLA-C | HLA class I histocompatibility antigen, C alpha chain | 0.705 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.84 | P17252 | PRKCA | Protein kinase C alpha type | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.852 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.833 | P67870 | CSNK2B | Casein kinase II subunit beta | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.704 | P11511 | CYP19A1 | Aromatase | P62879 | GNB2 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 | 0.704 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.851 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.739 | P11511 | CYP19A1 | Aromatase | P16298 | PPP3CB | Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform | 0.706 | P17252 | PRKCA | Protein kinase C alpha type | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.786 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P11511 | CYP19A1 | Aromatase | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 0.783 | P67870 | CSNK2B | Casein kinase II subunit beta | Q29983 | MICA | MHC class I polypeptide-related sequence A | 0.705 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P04141 | CSF2 | Granulocyte-macrophage colony-stimulating factor | -0.738 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P04141 | CSF2 | Granulocyte-macrophage colony-stimulating factor | 0.757 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P0DP23 | CALM1 | Calmodulin-1 | 0.775 | P17252 | PRKCA | Protein kinase C alpha type | P0DP23 | CALM1 | Calmodulin-1 | -0.776 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P0DP23 | CALM1 | Calmodulin-1 | -0.761 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P0DP23 | CALM1 | Calmodulin-1 | 0.761 | P11511 | CYP19A1 | Aromatase | P0CG47 | UBB | Polyubiquitin-B | -0.741 | P17252 | PRKCA | Protein kinase C alpha type | Q9UJU2 | LEF1 | Lymphoid enhancer-binding factor 1 | 0.881 |
| Idelalisib | hsa05168 | Herpes simplex virus 1 infection | 1.16E-04 | 15 | P25963, P01568, Q9GZY0, P42224, Q07955, Q01130, Q13243, Q9Y2A4, Q13398, P51522, P17038, Q03923, P52738, O75820, Q9UDV6 | NFKBIA, IFNA21, NXF2; NXF2B, STAT1, SFRS1, SFRS2, SFRS5, ZNF443, ZNF211, ZNF83, ZNF43, ZNF85, ZNF140, ZNF189, ZNF212 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.734 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | -0.739 | Q13627 | DYRK1A | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | -0.825 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P01568 | IFNA21 | Interferon alpha-21 | 0.729 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q9GZY0 | NXF2; NXF2B | Nuclear RNA export factor 2 | 0.704 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 1 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.912 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.864 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | -0.776 | Q13627 | DYRK1A | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | -0.703 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.743 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.758 | Q13627 | DYRK1A | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.781 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.805 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.87 | Q13627 | DYRK1A | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Q9Y2A4 | ZNF443 | Zinc finger protein 443 | 0.731 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | Q13398 | ZNF211 | Zinc finger protein 211 | 0.803 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q13398 | ZNF211 | Zinc finger protein 211 | -0.759 | Q13627 | DYRK1A | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | P51522 | ZNF83 | Zinc finger protein 83 | 0.851 | Q13627 | DYRK1A | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | P17038 | ZNF43 | Zinc finger protein 43 | 0.718 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | Q03923 | ZNF85 | Zinc finger protein 85 | -0.724 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q03923 | ZNF85 | Zinc finger protein 85 | 0.79 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P52738 | ZNF140 | Zinc finger protein 140 | 0.717 | Q13627 | DYRK1A | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | P52738 | ZNF140 | Zinc finger protein 140 | 0.71 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | O75820 | ZNF189 | Zinc finger protein 189 | -0.817 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | O75820 | ZNF189 | Zinc finger protein 189 | 0.715 | Q13627 | DYRK1A | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | O75820 | ZNF189 | Zinc finger protein 189 | 0.768 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | Q9UDV6 | ZNF212 | Zinc finger protein 212 | 0.738 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q9UDV6 | ZNF212 | Zinc finger protein 212 | -0.808 |
| Idelalisib | hsa05169 | Epstein-Barr virus infection | 5.94E-04 | 12 | P13765, P01106, Q13547, O00463, P42338, P07948, Q13761, P24522, O75293, P07766, P09693, P20963 | HLA-DOB, MYC, HDAC1, TRAF5, PIK3CB, LYN, RUNX3, GADD45A, GADD45B, CD3E, CD3G, CD247 | More | | Idelalisib | hsa05170 | Human immunodeficiency virus 1 infection | 9.21E-08 | 17 | P31751, P04049, Q02750, P62873, P62879, P16298, P0DP23, Q05397, P17252, Q14643, P01568, P51617, O60603, Q13315, P10415, Q9Y6Q5, P20333 | AKT2, RAF1, MAP2K1, GNB1, GNB2, PPP3CB, CALM1, PTK2, PRKCA, ITPR1, IFNA21, IRAK1, TLR2, ATM, BCL2, AP1M2, TNFRSF1B | More | | Idelalisib | hsa05171 | Coronavirus disease - COVID-19 | 1.36E-02 | 7 | P25963, P42224, P01568, P40189, P04141, P19174, P17252 | NFKBIA, STAT1, IFNA21, IL6ST, CSF2, PLCG1, PRKCA | More | | Idelalisib | hsa05200 | Pathways in cancer | 1.37E-05 | 22 | P08238, P42224, P25963, P19174, Q9UJU2, P17252, P43246, P14923, P10415, Q13489, Q13077, P49767, Q12778, P31751, P25116, P62873, Q9UM47, O75293, P0DP23, P01568, P14784, P40189 | HSP90AB1, STAT1, NFKBIA, PLCG1, LEF1, PRKCA, MSH2, JUP, BCL2, BIRC3, TRAF1, VEGFC, FOXO1, AKT2, F2R, GNB1, NOTCH3, GADD45B, CALM1, IFNA21, IL2RB, IL6ST | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.783 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.826 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 1 | P17252 | PRKCA | Protein kinase C alpha type | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.706 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.912 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.734 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | -0.739 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.851 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.739 | P17252 | PRKCA | Protein kinase C alpha type | Q9UJU2 | LEF1 | Lymphoid enhancer-binding factor 1 | 0.881 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | Q9UJU2 | LEF1 | Lymphoid enhancer-binding factor 1 | 0.768 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P17252 | PRKCA | Protein kinase C alpha type | -0.706 | P17252 | PRKCA | Protein kinase C alpha type | P17252 | PRKCA | Protein kinase C alpha type | 1 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P17252 | PRKCA | Protein kinase C alpha type | 0.832 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.789 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P43246 | MSH2 | DNA mismatch repair protein Msh2 | -0.768 | P17252 | PRKCA | Protein kinase C alpha type | P14923 | JUP | Junction plakoglobin | 0.761 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P14923 | JUP | Junction plakoglobin | 0.735 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | P14923 | JUP | Junction plakoglobin | 0.766 | P17252 | PRKCA | Protein kinase C alpha type | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.844 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.807 | P17252 | PRKCA | Protein kinase C alpha type | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.849 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | 0.801 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P49767 | VEGFC | Vascular endothelial growth factor C | -0.754 | P17252 | PRKCA | Protein kinase C alpha type | P49767 | VEGFC | Vascular endothelial growth factor C | 0.719 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P49767 | VEGFC | Vascular endothelial growth factor C | 0.761 | P17252 | PRKCA | Protein kinase C alpha type | Q12778 | FOXO1 | Forkhead box protein O1 | 0.863 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q12778 | FOXO1 | Forkhead box protein O1 | 0.753 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 1 | P17252 | PRKCA | Protein kinase C alpha type | P25116 | F2R | Proteinase-activated receptor 1 | 0.857 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.84 | P17252 | PRKCA | Protein kinase C alpha type | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.852 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.833 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.759 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | Q9UM47 | NOTCH3 | Neurogenic locus notch homolog protein 3 | 0.714 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | Q9UM47 | NOTCH3 | Neurogenic locus notch homolog protein 3 | -0.71 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.802 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.713 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P0DP23 | CALM1 | Calmodulin-1 | 0.775 | P17252 | PRKCA | Protein kinase C alpha type | P0DP23 | CALM1 | Calmodulin-1 | -0.776 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P0DP23 | CALM1 | Calmodulin-1 | -0.761 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | P0DP23 | CALM1 | Calmodulin-1 | -0.703 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P0DP23 | CALM1 | Calmodulin-1 | 0.761 | P17252 | PRKCA | Protein kinase C alpha type | P01568 | IFNA21 | Interferon alpha-21 | 0.733 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P01568 | IFNA21 | Interferon alpha-21 | 0.729 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.732 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P40189 | IL6ST | Interleukin-6 receptor subunit beta | -0.746 |
| Idelalisib | hsa05202 | Transcriptional misregulation in cancer | 8.84E-06 | 17 | Q12778, Q15532, Q13315, P14780, P27930, Q15744, Q16548, Q13077, O15550, P08069, P46527, P35226, P05164, P12838, P08246, Q9C0K0, P24522 | FOXO1, SS18, ATM, MMP9, IL1R2, CEBPE, BCL2A1, TRAF1, UTX, IGF1R, CDKN1B, BMI1, MPO, DEFA4, ELA2, BCL11B, GADD45A | More | | Idelalisib | hsa05203 | Viral carcinogenesis | 1.94E-06 | 12 | Q99941, P18848, P30279, P27348, Q13547, Q15283, P01889, P10321, P61978, P17612, P62807, O60814 | CREBL1, ATF4, CCND2, YWHAQ, HDAC1, RASA2, HLA-B, HLA-C, HNRPK, PRKACA, HIST1H2BC, H2BC12 | More | | Idelalisib | hsa05204 | Chemical carcinogenesis | 1.48E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Idelalisib | hsa05205 | Proteoglycans in cancer | 2.26E-03 | 6 | Q13009, Q12955, O75369, P04049, P08069, P08962 | TIAM1, ANK3, FLNB, RAF1, IGF1R, CD63 | More | | Idelalisib | hsa05206 | MicroRNAs in cancer | 1.08E-04 | 14 | P30304, P46527, P09493, P30279, Q9Y4H2, Q9UM47, P16070, Q13547, Q13315, P20827, P17252, P19174, P04049, Q02750 | CDC25A, CDKN1B, TPM1, CCND2, IRS2, NOTCH3, CD44, HDAC1, ATM, EFNA1, PRKCA, PLCG1, RAF1, MAP2K1 | More | | Idelalisib | hsa05210 | Colorectal cancer | 2.55E-03 | 3 | Q9UKG1, P04049, P37173 | APPL1, RAF1, TGFBR2 | More | | Idelalisib | hsa05211 | Renal cell carcinoma | 1.29E-03 | 2 | P31751, P04049 | AKT2, RAF1 | More | | Idelalisib | hsa05212 | Pancreatic cancer | 1.29E-03 | 2 | P31751, P04049 | AKT2, RAF1 | More | | Idelalisib | hsa05213 | Endometrial cancer | 4.41E-04 | 4 | O15169, P31751, Q02750, P04049 | AXIN1, AKT2, MAP2K1, RAF1 | More | | Idelalisib | hsa05214 | Glioma | 9.11E-08 | 7 | P08069, P0DP23, P17252, P04049, P31751, P19174, O75293 | IGF1R, CALM1, PRKCA, RAF1, AKT2, PLCG1, GADD45B | More | | Idelalisib | hsa05215 | Prostate cancer | 1.65E-04 | 2 | P08069, P04049 | IGF1R, RAF1 | More | | Idelalisib | hsa05217 | Basal cell carcinoma | 4.31E-02 | 2 | P04628, Q9UJU2 | WNT1, LEF1 | More | | Idelalisib | hsa05218 | Melanoma | 5.24E-06 | 3 | P08069, P31751, P04049 | IGF1R, AKT2, RAF1 | More | | Idelalisib | hsa05219 | Bladder cancer | 5.65E-03 | 3 | P14780, P04637, P04049 | MMP9, TP53, RAF1 | More | | Idelalisib | hsa05220 | Chronic myeloid leukemia | 9.63E-04 | 2 | P31751, P04049 | AKT2, RAF1 | More | | Idelalisib | hsa05221 | Acute myeloid leukemia | 8.16E-04 | 2 | P31751, P04049 | AKT2, RAF1 | More | | Idelalisib | hsa05222 | Small cell lung cancer | 4.78E-02 | 1 | P31751 | AKT2 | More | | Idelalisib | hsa05223 | Non-small cell lung cancer | 3.49E-04 | 2 | P31751, P04049 | AKT2, RAF1 | More | | Idelalisib | hsa05224 | Breast cancer | 2.75E-03 | 6 | P04049, P08069, P49841, Q92837, P04637, P24522 | RAF1, IGF1R, GSK3B, FRAT1, TP53, GADD45A | More | | Idelalisib | hsa05225 | Hepatocellular carcinoma | 1.65E-04 | 2 | P04049, P08069 | RAF1, IGF1R | More | | Idelalisib | hsa05226 | Gastric cancer | 3.48E-04 | 4 | P04049, Q02750, P31751, O15169 | RAF1, MAP2K1, AKT2, AXIN1 | More | | Idelalisib | hsa05230 | Central carbon metabolism in cancer | 1.12E-03 | 2 | P04049, P31751 | RAF1, AKT2 | More | | Idelalisib | hsa05231 | Choline metabolism in cancer | 1.89E-07 | 7 | P04049, Q9NRA1, Q9Y259, P19174, P23743, P49619, P17252 | RAF1, PDGFC, CHKB, PLCG1, DGKA, DGKG, PRKCA | More | | Idelalisib | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 6.41E-07 | 16 | P25963, P42338, O95267, P19174, P07766, P20963, P09693, P06239, P29350, P04049, P42224, O60603, P10747, Q04759, Q16539, P01730 | NFKBIA, PIK3CB, RASGRP1, PLCG1, CD3E, CD247, CD3G, LCK, PTPN6, RAF1, STAT1, TLR2, CD28, PRKCQ, MAPK14, CD4 | More | | Idelalisib | hsa05310 | Asthma | 1.92E-02 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Idelalisib | hsa05320 | Autoimmune thyroid disease | 1.27E-03 | 4 | P13765, P29965, P01568, P10747 | HLA-DOB, CD40LG, IFNA21, CD28 | More | | Idelalisib | hsa05321 | Inflammatory bowel disease | 1.27E-05 | 7 | O60603, P01375, P13765, Q14765, Q9UL17, P23771, Q9HBE5 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3, IL21R | More | | Idelalisib | hsa05322 | Systemic lupus erythematosus | 4.80E-06 | 10 | P08246, P09871, P10747, P13765, P29965, Q6FI13, Q93077, P62807, O60814, P68431 | ELA2, C1S, CD28, HLA-DOB, CD40LG, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Idelalisib | hsa05323 | Rheumatoid arthritis | 1.29E-02 | 4 | P13765, Q13488, P10747, O60603 | HLA-DOB, TCIRG1, CD28, TLR2 | More | | Idelalisib | hsa05330 | Allograft rejection | 1.04E-03 | 5 | P13765, P29965, P48023, P10747, P01375 | HLA-DOB, CD40LG, FASLG, CD28, TNF | More | | Idelalisib | hsa05332 | Graft-versus-host disease | 5.54E-06 | 6 | P13765, P48023, P10747, P01375, P26715, Q13241 | HLA-DOB, FASLG, CD28, TNF, KLRC1, KLRD1 | More | | Idelalisib | hsa05340 | Primary immunodeficiency | 2.19E-02 | 4 | P01730, P01732, P07766, P06239 | CD4, CD8A, CD3E, LCK | More | | Idelalisib | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 2.17E-03 | 1 | P54284 | CACNB3 | More | | Idelalisib | hsa05414 | Dilated cardiomyopathy | 4.55E-02 | 2 | P54284, P26678 | CACNB3, PLN | More | | Idelalisib | hsa05415 | Diabetic cardiomyopathy | 2.37E-04 | 8 | P17252, P30405, P14598, Q15080, Q16718, O14521, P37173, P04406 | PRKCA, PPIF, NCF1, NCF4, NDUFA5, SDHD, TGFBR2, GAPDH | More | | Idelalisib | hsa05416 | Viral myocarditis | 2.62E-02 | 3 | P13765, P29965, P10747 | HLA-DOB, CD40LG, CD28 | More | | Idelalisib | hsa05418 | Fluid shear stress and atherosclerosis | 1.27E-05 | 10 | Q16539, P31751, Q14145, P10599, P14780, P01375, P04637, P14778, P27930, P0DP23 | MAPK14, AKT2, KEAP1, TXN, MMP9, TNF, TP53, IL1R1, IL1R2, CALM1 | More | | |